CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Steven Sparagana

OPENALEX: A5008698867↗ORCID: 0000-0002-8439-4312↗

Affiliations

Organizations

Texas Scottish Rite Hospital for Childrenauthorship · US

Public evidence

1 connected articles

Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy.2019 · PubMed Central Open Access

Registered research

Connected studies

A Phase 1/2 Study to Assess the Pharmacokinetics and Safety of Multiple Doses of Pharmaceutical Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Seizure Disordersnct02324673 Evaluating the Efficacy of Cannabidiol for Reducing Cigarette Usenct06218056

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Steven Sparagana - Medical Cannabis Research Engine